Story perspectives

141,000 Lipitor Bottles Recalled Over Dissolution Concerns

10/26/2025

30 3

Summary

Story summary

Ascend Laboratories, a New Jersey pharmaceutical company, has recalled over 141,000 bottles of atorvastatin calcium tablets (Lipitor) in a Class II FDA recall.
The recall cites potential temporary health risks from the medication's failure to dissolve properly and notes that no illnesses have been reported.
The affected tablets, manufactured by Alkem Laboratories in India, are available in 10, 20, 40, and 80 mg dosages, with expiration through February 2027.

1 of 1

Story summary

Ascend Laboratories, a New Jersey pharmaceutical company, has recalled over 141,000 bottles of atorvastatin calcium tablets (Lipitor) in a Class II FDA recall.
The recall cites potential temporary health risks from the medication's failure to dissolve properly and notes that no illnesses have been reported.
The affected tablets, manufactured by Alkem Laboratories in India, are available in 10, 20, 40, and 80 mg dosages, with expiration through February 2027.